Rasagiline: Phase III data

In the U.S. and Canadian Phase III PRESTO trial in 472 patients, 26-week treatment with 1

Read the full 161 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE